Price Alert

Carisma Therapeutics Inc. (CARM)

NASDAQ: CARM · Real-Time Price · USD

0.45

-0.05 (-10.41%)

At close: Jun 20, 2025, 3:59 PM

Carisma Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	7.74M	17.91M	26.88M	40.36M	56.52M	77.61M	83.13M	76.35M	62.78M	133.55M	71.11M	39.7M	169.79M	28.55M	175.24M	151.04M	109.97M
Short-Term Investments	n/a	n/a	n/a	1.55M	1.55M	n/a	11.01M	40.73M	76.19M	54.37M	106.43M	41.91M	57.1M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	30K	30K	30K	30K	7.37M	19.64M	20K	20K	20K	20K	20K
Other Long-Term Assets	n/a	208K	208K	142K	142K	146K	146K	146K	n/a	4.11M	-14.8M	-19.64M	17.39M	-99.63M	7.35M	6.36M	258K
Receivables	n/a	n/a	n/a	2M	n/a	n/a	n/a	n/a	n/a	n/a	14.3M	n/a	2.05M	n/a	1.11M	2.3M	2.89M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-12.32M	n/a	-41.73M	n/a	n/a	n/a
Other Current Assets	6.21M	5.92M	6.01M	8.36M	4.44M	2.87M	3.43M	5.12M	5.54M	n/a	527K	n/a	8.79M	n/a	24.14M	21.76M	13.73M
Total Current Assets	13.95M	23.82M	34.14M	50.72M	60.95M	80.47M	97.56M	122.2M	144.5M	189.14M	192.36M	84.16M	180.64M	29.79M	200.48M	175.1M	126.58M
Property-Plant & Equipment	2M	6.42M	7.71M	8.48M	12.7M	8.94M	9.04M	10.64M	11.6M	13.45M	14.8M	13.2M	33K	5.66M	53K	109K	93K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-17.56M	n/a	n/a	27.76M	27.76M	27.76M	59.46M	59.46M
Total Long-Term Assets	2M	6.63M	7.92M	8.62M	12.84M	9.08M	9.22M	10.81M	11.63M	82.48M	7.37M	13.2M	45.2M	5.66M	35.19M	65.95M	59.84M
Total Assets	15.95M	30.46M	42.06M	59.34M	73.8M	89.55M	106.78M	133.01M	156.13M	271.63M	199.72M	97.36M	225.84M	35.45M	235.67M	241.05M	186.41M
Account Payables	3.25M	2.08M	1.73M	2.03M	2.17M	3.93M	2.41M	2.49M	4.61M	1.73M	514K	1.67M	666K	2.32M	3.91M	1.23M	2M
Deferred Revenue	41.25M	3.73M	682K	659K	1.19M	1.41M	1.19M	1.42M	2.14M	n/a	-33.17M	447K	n/a	n/a	n/a	1.5M	1.5M
Short-Term Debt	1.64M	1.74M	n/a	2.46M	n/a	1.94M	n/a	n/a	n/a	n/a	33.17M	n/a	n/a	n/a	n/a	n/a	288K
Other Current Liabilities	n/a	5.94M	3.45M	6.44M	5.04M	3.59M	6.18M	755K	755K	14.3M	-7.23M	n/a	5.13M	n/a	7.06M	14.3M	12.68M
Total Current Liabilities	10.45M	16.05M	10.56M	15.62M	13.14M	15.91M	12.95M	17.97M	21.48M	30.98M	34.7M	13.16M	8.47M	7.69M	12.59M	18.83M	17.37M
Long-Term Debt	687K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	33.72M	n/a	32.48M	n/a	n/a	-1.56M	n/a	n/a
Other Long-Term Liabilities	41.48M	318K	41.77M	815K	1.13M	926K	1.18M	1.81M	1.9M	46.89M	50.5M	49.52M	39.1M	n/a	58.16M	160.34M	147.25M
Total Long-Term Liabilities	42.17M	42.31M	42.63M	43.36M	49.76M	47.11M	47.53M	48.34M	48.59M	82.45M	52.2M	84.39M	44.57M	1.73M	62.07M	172.87M	159.78M
Total Liabilities	52.62M	58.37M	53.18M	58.98M	62.9M	63.02M	60.49M	66.31M	70.06M	113.44M	34.7M	97.54M	53.04M	9.43M	74.66M	191.7M	177.14M
Total Debt	2.33M	2.48M	3.32M	3.76M	7.49M	3.12M	2.75M	5.23M	5.47M	35.56M	34.88M	39.72M	n/a	2.63M	n/a	n/a	n/a
Common Stock	41K	41K	41K	41K	41K	40K	40K	40K	40K	202K	202K	199K	199K	199K	199K	188K	172K
Retained Earnings	-314.85M	-305.58M	-287.94M	-275.24M	-264.08M	-245.1M	-224.14M	-202.74M	-182.87M	-336.14M	-328.57M	-123.16M	-317.06M	-97M	-325.2M	-396.88M	-371.43M
Comprehensive Income	n/a	n/a	n/a	0.00	-0.00	-89.55M	373K	265K	136K	-546K	-235K	-197K	-96.18M	n/a	n/a	n/a	-911K
Shareholders Equity	-36.66M	-27.91M	-11.13M	360K	10.89M	26.53M	46.3M	66.7M	86.07M	158.19M	165.03M	-14.58M	172.8M	11.63M	161.01M	49.35M	9.27M
Total Investments	n/a	n/a	n/a	1.55M	1.55M	n/a	11.01M	40.73M	76.19M	54.4M	113.79M	89.09M	20K	20K	20K	20K	20K